Umbilical Cord-Derived Mesenchymal Stem Cells Are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Tesarova, Lenka, Jaresova, Klara, Simara, Pavel, Koutna, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432622/
https://www.ncbi.nlm.nih.gov/pubmed/32731615
http://dx.doi.org/10.3390/ijms21155366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432622/
https://www.ncbi.nlm.nih.gov/pubmed/32731615
http://dx.doi.org/10.3390/ijms21155366

Ejemplares similares